(Q46491009)

English

Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial

scientific article published in June 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18616861

Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18616861

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

object named as

Lieuwe de Haan

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18616861

6

object named as

Don Linszen

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18616861

Wim van den Brink

5

object named as

Wim van den Brink

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18616861

author name string

Lonneke J van Nimwegen

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18616861

Nico Jm van Beveren

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18616861

Mischa van der Helm

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18616861

language of work or name

0 references

publication date

1 June 2008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18616861

Canadian Journal of Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18616861

53

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18616861

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18616861

400-405

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18616861

Determinants of medication compliance in schizophrenia: empirical and clinical findings

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

Subjective response to antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

Subjective Well-being and Initial Dysphoric Reaction under Antipsychotic Drugs - Concepts, Measurement and Clinical Relevance

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

Medication adherence of individuals with a first episode of psychosis

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

Precipitation and determination of the onset and course of schizophrenia by substance abuse--a retrospective and prospective study of 232 population-based first illness episodes

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

Subjective experience and striatal dopamine D(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

Patterns of current and lifetime substance use in schizophrenia.

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

Prevalence of alcohol and drug abuse in schizophrenic inpatients

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

Influence of cannabis abuse on schizophrenic psychopathology

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

Cocaine and amphetamine use in patients with psychiatric illness: a randomized trial of typical antipsychotic continuation or discontinuation.

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

Occupancy of dopamine D2 receptors by antipsychotic drugs is related to nicotine addiction in young patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

A pilot trial of olanzapine for the treatment of cocaine dependence

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

Cocaine abuse in schizophrenic patients treated with olanzapine versus haloperidol

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

A double-blind placebo-controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

Psychometric properties of the Subjective Well-Being Under Neuroleptics scale and the Subjective Deficit Syndrome Scale.

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

Initial validation of two opiate craving questionnaires the obsessive compulsive drug use scale and the desires for drug questionnaire.

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

Risperidone diminishes cocaine-induced craving

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: a preliminary report.

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

Olanzapine reduces urge to drink after drinking cues and a priming dose of alcohol

1 reference

https://api.crossref.org/works/10.1177%2F070674370805300610

21 January 2018

Identifiers

10.1177/070674370805300610

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18616861

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46491009&oldid=2113677622"